Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Gene signature governs anti-plaque microglia in AD

May 28, 2021

New opioid receptor agonists identified at Fudan University

May 27, 2021

FDA clears IND for phase I/II study of LION-101 gene therapy as treatment of LGMD2I/R9

May 27, 2021

FDA places clinical hold on Larimar's CTI-1601 for Friedreich's ataxia

May 26, 2021

Nasally administered foralumab studied in secondary progressive multiple sclerosis

May 25, 2021

Long-term reduced dose regimen with sargramostim shows improved safety in patients with PD

May 25, 2021

New N-acetyl-beta-D-glucosaminidase inhibitors described by Biogen

May 25, 2021

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent 5-HT2A antagonists/DRD3 agonists

May 25, 2021

Phase I study evaluates gene therapy AAV9/CLN7 in Batten disease

May 21, 2021

Biogen identifies BTK inhibitors

May 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...